Home' Australian Journal of Pharmacy : Jan-Feb 2017 Contents CHRIS BROOKER
Six pharmacies from across Australia have been named as finalists in this
year’s prestigious Guild Pharmacy of the Year Awards.
The Guild says the awards are a highlight of the pharmacy calendar
where pharmacies that are leading the way in prov iding innovative and
optimal healthcare for members of their community are recognised
The six finalists are:
• Lucy Walker Chemmart Goondiwindi, Queensland;
• Capital Chemist Southlands, Mawson, Australian Capital Territory;
• Capital Chemist Wanniassa, Australian Capital Territory;
• Waikerie Chemplus, South Australia ;
• Terry White Chemmart Hawthorn, Victoria; and
• Beaufort St 24 hour Chemist, Perth, Western Australia.
A spokesperson for the judging group, Nick Panayiaris, Pharmacy Guild
of Australia national councillor and president of the South Australian
Branch of the Guild, says a feature of nominations in this year’s Pharmacy
of the Year awards is the commitment to high-quality service delivery.
For more on each of the finalists, see our feature beginning on page 17.
‘SILLY’ DECISION WON’T
CURB CODEINE MISUSE
A spokesperson for the Pharmacy Guild told the AJP that the TGA’s
decision to upschedule the medicines from 1 February 2018 will
disadvant age many people who currently use them appropriately.
“The demand for codeine products will remain, and there is no evidence
that making codeine products prescription-only will reduce demand or
abuse,” the spokesperson says.
“This is not about loss of money for pharmacy, rather this is a public
health issue and anyone thinking it will reduce abuse hasn’t been listening
to newspaper reports or coroner’s reports.”
Pharmacy Guild national president George Tambassis told the To d a y
program: “There is no real-time monitoring system under prescription-
only, doctors haven’t got any access to other doctor surgeries. We believe a
real-time monitoring system is the only way to go with these medicines.”
He cited MedsASSIST data showing 98% of Australians were using
codeine-containing Pharmacy Only and Pharmacist Only medicines
The TGA said it made the decision “after significant consideration and
consultation on the effects of medicines containing codeine on people’s
health and wellbeing”.
The change does not come into place until 1 February 2018 so there will
be no change to the availability of products occurring now or in 2017.
Doctors groups welcomed the move, with R ACGP President Dr Bastian
Seidel saying his organisation had long supported the up-scheduling as a
“neces sary step to improve patient safety and reduce harm”.
“Until now OTC codeine combination analgesics have been sold over the
counter in pharmacies, virtually unmonitored or unregulated, while other
opioids are only legally accessible through prescriptions from medical
practitioners,” he said.
“Unfortunately, the harm caused by these medicines has not been
reduced by restricting them to pharmacy-only”.
Do industry-specific issues ‘trump’ real-world impacts? There
really is a lot of negativity around pharmacy as we kick off 2017.
Is this warranted? Or is it worse than at previous times of
crisis? I can’t definitively say, although a number of business
insiders do think that the conglomeration of a number of
individual issues is creating a perhaps unique situation.
One simple, stark fact though is that there’s not much
that can be done on many of these issues. Government
policy isn’t going to change radically on PBS cuts, the rental
situation isn’t going to miraculously fix itself, nor is the
overall economic mood going to alter in a hurry.
So as an individual pharmacy, you can really only impact
your own situation directly. You can affect your pharmacy’s
presentation and approach, you can decide which
particular pharmacy model or banner suits your community
demographic and location.
You can pursue varied and creative forms of local
advertising, you can use resources provided by pharmacy
bodies and others to aid in promotion and marketing.
Either way, the buck (to some extent) stops with you.
Mind you, there’s not much we can do about the financial
impact of Trump or other ‘real-world’ problems...
As we embark on 2017, I encourage readers to get in touch
w ith us on any issues they feel we should cover, respond to
features and articles we run, and participate on our online
forum and reader comment sections.
Our aim is to use reader responses to our online and
newsletter articles and polls to inform the more in-depth
coverage we provide in the monthly magazine. This allows
our stories to be guided by reader perspectives.
I also want to briefly mention some of the exciting plans
we have in the digital space in 2017, especially around our
coverage of APP.
This year we will be presenting a daily newsletter from
pharmacy’s biggest conference, plus prov iding extensive
video and social media coverage of the event.
We’re looking forward, in particular, to our new video
platform which will allow those not actually at the event to
experience more than a taste of the conference.
All in all it will be a busy year, for the AJP and
PHARMACY OF THE YEAR
NEWS WRAP SEE AJP.COM.AU FOR DAILY NEWS
Links Archive December 2016 March 2017 Navigation Previous Page Next Page